In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 1, 1996, Pages 117-126

  Edelstein, Paul H ^a   Edelstein, Martha A C ^a   Lehr, K H ^b   Ren, Jianjun ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; ESCHERICHIA COLI; EXPERIMENTAL INFECTION; GROWTH INHIBITION; GUINEA PIG; INTRAPERITONEAL DRUG ADMINISTRATION; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PNEUMONIA;

ANIMALS; ANTI-INFECTIVE AGENTS; GUINEA PIGS; HUMANS; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; MALE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN;

EID: 0029989563     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.1.117     Document Type: Article

References (24)

1. Bertrand, A., Janbon, F., Despaux, E., Jonquet, O. & Reynes, J. (1987). L'ofloxacine (RU 43280). Etude clinique. Pathologie Biologie 35, 629-33.
2. Davis, R. & Bryson, H. M. (1994). Levofioxacin. A review of its antibacterial activity, pharmacokinetic and therapeutic efficacy. Drugs 47, 677-700.
3. DeForges, L., Fournet, M. P., Soussy, C. J. & Duval, J. (1986). Etude de l'activitité antibactérienne in vitro de dix quinolones sur vingt souches de Legionella pneumophila. Pathologie Biologie 34, 631-3.
4. Edelstein, P. H. (1985). Legionnaires' Disease Laboratory Manual, 3rd edn. National Technical Information Service, Springfield, VA.
5. Edelstein, P H. (1995). Antimicrobial therapy of Legionnaires' disease - A review. Clinical Infectious Diseases.
6. Edelstein, P. H., Calarco, K. & Yasui, V. K. (1984). Antimicrobial therapy of experimentally induced Legionnaires' disease in guinea pigs. American Review of Respiratory Diseases 130, 849-56.
7. Edelstein, P. H. & Edelstein, M. A. C. (1989). WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages. Antimicrobial Agents and Chemotherapy 33, 2132-6.
8. Edelstein, P. H. & Edelstein, M. A. C. (1991). In vitro activity of azithromycin against clinical isolates of Legionella species. Antimicrobial Agents and Chemotherapy 35, 180-1.
9. Edelstein, P. H. & Edelstein, M. A. C. (1993). Comparison of three buffers used in the formulation of buffered charcoal yeast extract medium. Journal of Clinical Microbiology 31, 3329-30.
10. Edelstein, P. H., Edelstein, M. A. C., Weidenfeld, J. & Dorr, M. B. (1990). In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. Antimicrobial Agents and Chemotherapy 34, 2122-7.
11. Fitzgeorge, R. B., Featherstone, A. S. & Baskerville, A. (1988). The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes. Journal of Antimicrobial Chemotherapy 22, Suppl. C, 53-7.
12. Fujimoto, T. & Mitsuhashi S. (1990). In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin. Chemotherapy 36, 268-76.
13. Gaja, M. (1992). In vitro and in vivo antibacterial activity of four newly developed quinolone agents against Legionella infection. Chemotherapy 40, 1-10.
14. Hardy, D. J. (1991). In vitro activity of temafloxacin against gram-negative bacteria: an overview. American Journal of Medicine 91, Suppl. 6A, 19S-23.
15. Havlichek, D., Saravolatz, L. & Pohlod, D. (1987). Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophila. Antimicrobial Agents and Chemotherapy 31, 1529-34.
16. Horwitz, M. A. & Silverstein, S. C. (1983). Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin. Journal of Clinical Investigation 71, 15-26.
17. Jacobs, M. R. (1991). Evaluation of the bactericidal activity of temafloxacin. American Journal of Medicine 91, Suppl. 6A, 31S-4.
18. Kitsukawa, K., Hara, J. & Saito, A. (1991). Inhibition of Legionella pneumophila in guinea pig peritoneal macrophages by new quinolone, macrolide and other antimicrobial agents. Journal of Antimicrobial Chemotherapy 27, 343-53.
19. Leroy, O., Beuscart, C., Chidiac, C., Sivery, B., Senneville, E., Vincent du Laurier, M. et al. (1989). Traitement des pneumonies dues aux légionelles, mycoplasmes, Chlamydiae, et rickettsies par Tofloxacine. Pathologie Biologie 37, 1137-40.
20. Mouton, Y., Leroy, O., Beuscart, C., Sivery, B , Senneville, E., Chidiac, C. et al. (1990). Efficacy of intravenous ofloxacin: a French multicentre trial in 185 patients. Journal of Antimicrobial Chemotherapy 26, Suppl. D , 115-21.
21. Rajagopalan-Levasseur, P., Dournon, E., Dameron, G., Vilde, J. L. & Pocidalo, J. J. (1990). Comparative postantibacterial activities of perfloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication of Legionella pneumophila serogroup 1. Antimicrobial Agents and Chemotherapy 34, 1733-8.
22. Saito, A., Sawatari, K., Fukuda, Y., Nagasawa, M., Koga, H., Tomonaga, A. et al. (1985). Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs. Antimicrobial Agents and Chemotherapy 28, 15-20.
23. Vildé, J. L., Dournon, E. & Rajagopalan, P. (1986). Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents. Antimicrobial Agents and Chemotherapy 30, 743-8.
24. Wynckel, A., Toupance, O., Melin, J. P., David, C., Lavaud, S., Wong, T. et al. (1991). Traitement des legionelloses par ofloxacine chez le transplante renal. Absence d'interférence avec la ciclosporine A. Presse Medicale 20, 291-3.